Compare GRWG & ELUT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | GRWG | ELUT |
|---|---|---|
| Founded | 2008 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | RETAIL: Building Materials | Medical Specialities |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 96.7M | 41.9M |
| IPO Year | 2015 | 2020 |
| Metric | GRWG | ELUT |
|---|---|---|
| Price | $1.48 | $0.94 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 1 |
| Target Price | $2.50 | ★ $6.00 |
| AVG Volume (30 Days) | ★ 342.4K | 86.4K |
| Earning Date | 05-08-2026 | 05-08-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 51.22 | ★ 146.77 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $193,365,479.00 | $12,293,000.00 |
| Revenue This Year | $5.09 | N/A |
| Revenue Next Year | N/A | $10.83 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 142.51 | N/A |
| 52 Week Low | $0.96 | $0.50 |
| 52 Week High | $2.40 | $2.60 |
| Indicator | GRWG | ELUT |
|---|---|---|
| Relative Strength Index (RSI) | 47.93 | 42.45 |
| Support Level | $1.43 | $0.86 |
| Resistance Level | $1.61 | $0.99 |
| Average True Range (ATR) | 0.08 | 0.06 |
| MACD | -0.01 | -0.00 |
| Stochastic Oscillator | 53.85 | 13.75 |
GrowGeneration Corp owns and operates specialty retail stores focused on hydroponic and organic gardening. The company markets and distributes nutrients, growing media, indoor and greenhouse lighting, ventilation systems, and related accessories. It operates through two reportable segments: Cultivation and Gardening, which includes its hydroponic and organic gardening business, and Storage Solutions, which includes its benching, racking, and storage solutions operations. The company generates revenue mainly from the sale of proprietary and non-proprietary products through retail stores, e-commerce platforms, wholesale distribution, and commercial sales, along with the sale and installation of commercial fixtures.
Elutia Inc develops proprietary drug-eluting biomatrix products for use in surgical reconstruction and related applications. These products are designed to improve the interaction between implanted medical devices and patients. Its products include CanGaroo, designed for implantable electronic devices, and SimpliDerm, used in soft tissue repair, with functions related to implant support and wound management. The company operates in two segments: Women's Health and Cardiovascular. The majority of revenue is derived from the Women's Health segment.